The role of modern biology and medicine in drug development in academia and industry.
This symposium addresses careers in drug development in industry; the performance of translational research by academia, industry, and both; and numerous factors pertinent to alliances essential to drug discovery and development. Drug development is a complex process that regularly involves effective collaborations between academic and physician scientists and industry. There are specific occupational factors affecting recruitment of scientists and physicians in drug development programs in industry; ideal backgrounds for successful applicants for positions in industry in drug development; ethical and regulatory considerations particularly germane to the performance of scientists and physicians in drug development programs in industry and at universities; and particular gratifications available to scientists in industry working on drug development. Both similarities and differences characterize the performance of translational research in industry compared with academia. In industry, logistic, operational, and scientific oversight is complex, especially because it often involves relationships with clinical enterprises outside of the corporation. The process is long and arduous from formulation of a good idea in discovery to acceptance of a novel drug in the marketplace. Collaborations and partnerships by industry often involving academia and confrontation of multiple issues are pivotal.
Blake
Charles A
CA
Department of Cell and Developmental Biology and Anatomy, University of South Carolina, School of Medicine, Columbia, SC 29208, USA. blake@med.sc.edu
Barker
Kenneth L
KL
Sobel
Burton E
BE
D000046:Academic Medical Centers; D006801:Humans; D007221:Industry / Q000639:trends*; D007400:Interprofessional Relations; D010820:Physicians; D012106:Research / Q000639:trends*; D012586:Science / Q000639:trends*; D013678:Technology, Pharmaceutical / Q000379:methods* / Q000639:trends